Category: Regulatory

Quantitative Structure-Activity Relationship: A Key Tool in Modern Drug Development In modern pharmaceutical research, data-driven and computational approaches are transforming the way new medicines are discovered. One such powerful method is the Quantitative Structure-Activity Relationship (QSAR).

Guidelines on Environmental Risk Assessment (ERA) for Medicinal Products: A Complete Pharma Regulatory Guide Environmental sustainability has become a major focus in the pharmaceutical industry, making Environmental Risk Assessment (ERA) for Medicinal Products an important part of regulatory compliance.

A Complete Guide to QSAR Modeling in Pharmaceutical Research and Development In modern pharmaceutical research, computational tools are increasingly shaping how drug candidates are identified, evaluated, and optimized. Among these tools, QSAR (Quantitative Structure–Activity Relationship) modeling has emerged as a key scientific approach in drug discovery and development.

What is Clinical Medical Writing? In the pharmaceutical and clinical research industry, clear and accurate documentation is essential for developing safe and effective medicines. Medical writing in clinical research is the process of preparing scientifically accurate documents that support clinical trials, regulatory submissions, and drug development activities.

EU Requirements for Environmental Risk Assessment (ERA): Key Steps for Pharma Regulatory Compliance In the European pharmaceutical landscape, Environmental Risk Assessment (ERA) has become a mandatory component of regulatory submissions. The EU requirements for ERA ensure that medicinal products are evaluated not only for safety and efficacy but also for their potential environmental impact.

What Is Regulatory Medical Writing? In the pharmaceutical and life sciences industry, accurate documentation is essential for regulatory approval and successful drug development. Regulatory medical writing is the specialized process of creating scientifically accurate and compliant documents required by health authorities.

eCTD Publishing Standards for Accurate and Compliant Regulatory Submissions The current regulatory landscape has made electronic submissions a pre-requisite for pharmaceutical and biotechnology companies across the globe. eCTD publishing standards guarantee that regulatory submissions are well-structured, validated and compliant with health authority requirements like FDA, EMA, MHRA, Health Canada and PMDA.

US FDA eCTD Submission: Streamlining Regulatory Compliance for Faster Approvals According to the US FDA eCTD submission process, the electronic Common Technical Document (eCTD) is an essential submission for pharmaceutical, biotechnology, and life sciences companies to gain approvals in the United States.

How Regulatory Quality Modules Streamline Compliance and Documentation In the pharmaceutical industry, maintaining compliance and accurate documentation is critical for ensuring product quality, patient safety, and adherence to global regulatory standards.

A Step-by-Step Guide to Pharma Product Submission Management in the Pharma Industry Pharma Product Submission Management is a crucial process in the highly regulated pharmaceutical industry, ensuring that new drugs, formulations, and bio pharmaceuticals are approved on time.